About Dev Chatterjee
Dev Chatterjee is a chief executive officer at Goldenrod Therapeutics.
Experience
This experience comes from Dev Chatterjee's profile and from SEC filings. For roles taken from filings, the years are when the filings name Dev Chatterjee in the role, so the role may have started earlier or lasted longer.
Goldenrod Therapeutics, Inc. Current
Chief Executive Officer
2026 – Present · Houston, TX
Develops medicines for people with neurological diseases, initially targeting Friedreich’s ataxia.
FA
Fannin Current
Managing Director
2013 – Present
BL
BreviTest Technologies, LLC Current
Chief Scientific Officer
2013 – Present
AP
American Journal of Cancer Therapy and Pharmacology
Associate Editor
2012 – 2013
MC
M D Anderson Cancer Center
Postdoctoral Research Fellow
2010 – 2013
NS
National University of Singapore
Research fellow
2003 – 2010
U1
Université de Rennes 1
Visiting post-doctoral research fellow
2009
CL
Caveat Pte Ltd
Founder and CEO
2007 – 2009
SA
Scuola Superiore Sant’Anna
Research Intern
2002
Key Colleagues at Startups
The people Dev Chatterjee works with at each company, as listed on that company's latest Form D.
Goldenrod Therapeutics, Inc. · Form D, Jun 3, 2026
LI
Leo Linbeck IV
Executive officer
Mark Worscheh
Chief Financial Officer and director
Atul Varadhachary
President and director
LI
Leo Linbeck III
Director
TB
Thomas Brenninkmeijer
Director